SLC6A6 and acute myeloid leukemia: Consistent with a key role of TAUT expression in myeloid leukaemia initiation, TAUT loss in disease driven by AML-ETO9a resulted in a marked increase in survival (70%) relative to the controls (0%) (36.3-fold higher likelihood of survival; Fig. 3m,n).